Genetic analysis of endometriosis and depression identifies shared loci and implicates causal links with gastric mucosa abnormality by Adewuyi, Emmanuel et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
9-21-2020 
Genetic analysis of endometriosis and depression identifies 
shared loci and implicates causal links with gastric mucosa 
abnormality 
Emmanuel Adewuyi 





See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Life Sciences Commons, Medicine and Health Sciences Commons, Physical Sciences and 
Mathematics Commons, and the Psychology Commons 
10.1007/s00439-020-02223-6 
This is a post-peer-review, pre-copyedit version of an article published in Human Genetics. The final authenticated 
version is available online at: http://dx.doi.org/10.1007/s00439-020-02223-6 
Adewuyi, E. O., Mehta, D., Sapkota, Y., Auta, A., Yoshihara, K., Nyegaard, M., ... Nyholt, D. R. (2021). Genetic analysis 
of endometriosis and depression identifies shared loci and implicates causal links with gastric mucosa 
abnormality. Human Genetics, 140(3), 529-552. https://doi.org/10.1007/s00439-020-02223-6 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/10811 
Authors 
Emmanuel Adewuyi, Divya Mehta, Yadav Sapkota, Asa Auta, Kosuke Yoshihara, Mette Nyegaard, Lyn R. 
Griffiths, Grant W. Montgomery, Daniel I. Chasman, and Dale R. Nyholt 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/10811 
1 
 
Genetic analysis of endometriosis and depression identifies shared loci and implicates 
causal links with gastric mucosa abnormality  
Emmanuel O. Adewuyi1*. Divya Mehta1. Yadav Sapkota2. International Endogene 
Consortium†. 23andMe Research Team3,†. Asa Auta4. Kosuke Yoshihara5. Mette Nyegaard6,7. 
Lyn R. Griffiths1. Grant W. Montgomery8. Daniel I. Chasman9. Dale R. Nyholt1* 
 
1School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical 
Innovation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia 
2Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, 
Memphis, Tennessee 38105, USA 
323andMe, Inc., 223 N Mathilda Ave, Sunnyvale, CA 94086, USA 
4School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 
2HE, UK 
5Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical 
and Dental Sciences, Niigata 950-2181, Japan 
6Department of Biomedicine – Human Genetics, Aarhus University, Aarhus, DK-8000 Aarhus, 
Denmark 
7iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, 
Copenhagen, DK-2100 Copenhagen, Denmark 
8Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 
4072, Australia 
9Divisions of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, 
Harvard Medical School, Boston, MA, USA. 
 
†Full lists of consortia members appear at the end of the paper  
Correspondence: emmanuel.adewuyi@qut.edu.au; d.nyholt@qut.edu.au  
Acknowledgments:  
We acknowledge all the study participants in the 11 individual endometriosis studies that 
provided an opportunity for the current study. We also thank many hospital directors and staff, 
gynaecologists, general practitioners, and pathology services in Australia who helped with 
confirmation of diagnoses. We would like to thank the research participants and employees of 
23andMe for making this work possible. We thank the subjects of the Icelandic deCODE study 
for their participation. We thank the research staff and clinicians for providing diagnostic 
2 
 
confirmation for the OX data set. We would like to express our gratitude to the staff and 
members of the Biobank Japan and Laboratory for Statistical Analysis, RIKEN Center for 
Integrative Medical Sciences for their outstanding assistance. A full list of the investigators 
who contributed to the generation of these data is available from http://www.wtccc.org.uk. We 
gratefully appreciate the PGC for providing access to their depression and MDD GWAS 
summary data. Also, we acknowledge the generosity of UKB and other relevant bodies 
(QSKIN study, and GWAS Atlas) for providing open access to their GWAS summary data. 
Last but not least, we appreciate members of the Statistical and Genomic Epidemiology 
Laboratory (SGEL) at the Queensland University of Technology, Brisbane (Dale, Divya, Anita, 
Emmanuel, Ammarah, Sana, Linduni, Hamzeh, and Rafiqul), for their support and 
encouragement towards the successful completion of this work. 
Declaration 
Funding:  
EOA was supported by the Queensland University of Technology Postgraduate Research 
Awards (QUTPRA). The QIMR study was supported by grants from the National Health and 
Medical Research Council (NHMRC) of Australia (241,944, 339,462, 389,927, 389,875, 
389,891, 389,892, 389,938, 443,036, 442,915, 442,981, 496,610, 496,739, 552,485, 552,498, 
1,026,033 and 1,050,208), the Cooperative Research Centre for Discovery of Genes for 
Common Human Diseases (CRC), Cerylid Biosciences (Melbourne) and donations from N. 
Hawkins and S. Hawkins. Analyses of the QIMRHCS and OX GWAS were supported by the 
Wellcome Trust (WT084766/Z/08/Z) and makes use of WTCCC2 control data generated by 
the Wellcome Trust Case-Control Consortium (awards 076113 and 085475). The iPSYCH 
study was funded by The Lundbeck Foundation, Denmark (R102-A9118, R155-2014-1724), 
and the research has been conducted using the Danish National Biobank resource supported by 
the Novo Nordisk Foundation. The Japanese GWA study was funded by the BioBank Japan 
project, which is supported by the Ministry of Education, Culture, Sports, Sciences and 
Technology of the Japanese government.  
Conflicts of interest/Competing interests  
All researchers had full independence from the funders. The authors report no biomedical 




Ethics approval  
This study has been included in the ‘genetic analysis and comorbid PSYCHIATRIC disorders 
using twin families’ (P5890) project in the ‘genetic epidemiology portfolio’. The Human 
Research Ethics Committee had earlier granted ethical approval for the project and approval 
for the addition of the present study was granted on the 3rd of November 2017.  
Consent to participate  
Not applicable  
Consent for publication  
Not applicable 
Availability of data and material (data transparency) 
The present study was based on a secondary analysis of GWAS data, and all data generated 
during the study are included in this published article [and its supplementary files]. The GWAS 
data analysed for depression and MDD are available and accessible online by contacting the 
PGC. The GWAS data for GERD and gastritis/duodenitis are freely accessible using the links 
provided within the articles. The endometriosis GWAS data were sourced from the 
International Endogen Consortium (IEC); for access to these, contact the consortium directly. 














Evidence from observational studies indicates that endometriosis and depression often co-
occur. However, conflicting evidence exists, and the etiology as well as biological mechanisms 
underlying their comorbidity remain unknown. Utilizing genome-wide association study 
(GWAS) data, we comprehensively assessed the relationship between endometriosis and 
depression. Single nucleotide polymorphism effect concordance analysis found a significant 
genetic overlap between endometriosis and depression (PFsig-permuted = 9.99 × 10-4). Linkage 
disequilibrium score regression analysis estimated a positive and highly significant genetic 
correlation between the two traits (rG = 0.27, P = 8.85 × 10-27). A meta-analysis of 
endometriosis and depression GWAS (sample size = 709,111), identified 20 independent 
genome-wide significant loci (P < 5 × 10-8), of which eight are novel. Mendelian randomization 
analysis suggests a causal effect of depression on endometriosis. Combining gene-based 
association results across endometriosis and depression GWAS, we identified 22 genes with a 
genome-wide significant Fisher’s combined P value (FCPgene < 2.75 × 10-6). Genes with a 
nominal gene-based association (Pgene < 0.05) were significantly enriched across endometriosis 
and depression (Pbinomial-test = 2.90 × 10-4). Also, genes overlapping the two traits at Pgene < 0.1 
(Pbinomial-test = 1.31 × 10-5) were significantly enriched for the biological pathways ‘cell-cell 
adhesion’, ‘inositol phosphate metabolism’, ‘Hippo-Merlin signaling dysregulation’ and 
‘gastric mucosa abnormality’. These results reveal a shared genetic etiology for endometriosis 
and depression. Indeed, additional analyses found evidence of a causal association between 
each of endometriosis and depression and at least one abnormal condition of gastric mucosa. 
Our study confirms the comorbidity of endometriosis and depression, implicates links with 
gastric mucosa abnormalities in their causal pathways and reveals potential therapeutic targets 
for further investigation.  
 
Keywords: depression, endometriosis, genome-wide association study, molecular genetics, 








Endometriosis is one of the leading gynecological disorders defined by the presence of 
endometrial tissues in sites other than within the endometrial cavity (Adamson et al. 2010; 
Giudice 2010; Treloar et al. 1999). The disorder continues to be a subject of increasing global 
public health importance, affecting approximately 10% of reproductive-aged women, and, up 
to 50% of women with infertility or sub-fertility, worldwide (Giudice 2010; Zondervan et al. 
2018). Menstrual irregularities, dysmenorrhea, and varying degrees of chronic pelvic pains are 
among the most common clinical signs of endometriosis (Laganà et al. 2015; Tripoli et al. 
2011). Depression, on the other hand, is a chronic psychiatric illness characterized primarily 
by social dysfunction, feelings of guilt or low self-worth, cognitive impairment, loss of- and 
changes in sleep, appetite, and libido as well as a substantial deterioration in mood and 
behaviors (Lépine and Briley 2011; World Health Organization 2017). Similar to 
endometriosis, which is predominantly found in women, depression ranks as the leading cause 
of disease burden among women and is associated with increased risks of morbidity and 
mortality (Kuehner 2017; Lépine and Briley 2011; Mathers 2008; Rei et al. 2018). 
Both endometriosis and depression carry considerable personal, social, as well as economic 
burdens on sufferers, their families, and indeed the larger society (Greenberg et al. 2015; Rush 
and Misajon 2018). A recent study (Rush and Misajon 2018), for example, reveals that the 
personal wellbeing index for women with endometriosis was lower than those reported for 
other chronic diseases including cancers and HIV/AIDS (Cummins et al. 2009; Hutton et al. 
2013). Similarly, compared to the general population, depressed patients have over 20-fold 
increased risks of mortality from suicide (Bachmann 2018; Lépine and Briley 2011; Ösby et 
al. 2001). Despite the consistent evidence on the growing global burden of endometriosis and 
depression (Chisholm et al. 2016; Lépine and Briley 2011; Rush and Misajon 2018), their 
adverse impacts on patients’ quality of life and consequences for higher risks of morbidity, 
infertility (endometriosis) and mortality (depression), the two disorders remain 
underdiagnosed, often misdiagnosed and undertreated, worldwide (Bedaiwy et al. 2017; 
Centers for Disease Control and Prevention 2010; Ghai et al. 2020; Lépine and Briley 2011; 
Ricky and O’Donnell Siobhan 2017). Also, while several theories have been proposed to 
explain the pathogenesis of endometriosis (Burney and Giudice 2012; Sampson 1925; Sourial 
et al. 2014) and depression (Gałecki and Talarowska 2018; Hasler 2010), the etiologies of the 
two disorders remain relatively obscure. There is currently no sufficient evidence on the 
effectiveness of laboratory diagnostic markers for endometriosis or depression just as no 
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known treatment offers curative assurance for any of them (Bedaiwy et al. 2017; Gupta et al. 
2016; Marian and Hermanowicz-Szamatowicz 2020; Strawbridge et al. 2018). 
Evidence from observational studies indicates that a significant association exists between 
endometriosis and depression (Cavaggioni et al. 2014; Lorencatto et al. 2006; Pope et al. 2015). 
For example, a study in the United States, found the prevalence of depression to be nearly two-
fold higher among women with endometriosis than in the general population (6.8% vs 3.9%, P 
< 0.001) (Mirkin et al. 2007). Another study reported more than twice the prevalence of 
depression in endometriosis cases compared to controls (39.4% vs 18.6%, P = 0.045) in an 
Italian population (Cavaggioni et al. 2014). A longitudinal follow-up study similarly found 
elevated risks of major depression and any depression among endometriosis patients with 
estimated hazard ratios (HR) of 1.56 (95%CI: 1.24–1.97) and 1.44 (95%CI: 1.25–1.65), 
respectively (Chen et al. 2016). More recently, another longitudinal study reported 
bidirectional relationships between endometriosis and several psychiatric disorders including 
depressive disorders (endometriosis as the outcome variable [Adjusted HR = 1.89 (95%CI: 
1.78–2.01)]; depressive disorder as the outcome variable [Adjusted HR = 1.81 (95%CI: 1.71–
1.92)]) (Gao et al. 2020). These associations are supported also in animal models; female mice 
with induced endometriosis were found to be ‘more depressed’, and ‘anxious compared to 
sham controls’ with evidence for gene expression alterations in the brain (Li et al. 2018). 
Similar findings were reported in another recent animal study in rats models (Lima Filho et al. 
2019). Comorbid depression in endometriosis patients may predispose to disease worsening, 
poor prognosis, lower quality of life and increased cost of treatments (Mirkin et al. 2007; 
Valderas et al. 2009). 
Notwithstanding the number of studies reporting a significant association between 
endometriosis and depression, the biological mechanism(s) underlying their possible comorbid 
relationship remain(s) unknown. A recent systematic review and meta-analysis of cross-
sectional studies concluded that the association between endometriosis and depressive 
symptoms is largely determined by chronic pain (Gambadauro et al. 2019). The study reported 
that i) endometriosis patients with pelvic pain had higher levels of depressive symptoms 
compared to endometriosis patients without pelvic pain (Gambadauro et al. 2019), and ii) 
women with pelvic pain and endometriosis do not have higher levels of depressive symptoms 
compared to women with pelvic pain and no endometriosis. These results are consistent with 
the previous finding of when pain is moderate to severe, it is associated with more depressive 
symptoms (Bair et al. 2003); and suggest that depressive symptoms are related to chronic pain 
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rather than endometriosis (Gambadauro et al. 2019). However, further interpretation of these 
results is limited due to their reliance on cross-sectional data (Gambadauro et al. 2019). Also, 
given that both endometriosis and depression are complex disorders, we hypothesize that pain 
does not seem plausible for a complete explanation of their potential comorbid relationship. 
Moreover, several other studies did not find a significant association between endometriosis 
and depressive symptoms (Cavaggioni et al. 2014; Gambadauro et al. 2019; Novais et al. 2018). 
Hence, clear, and convincing evidence on the comorbidity, as well as the possible biological 
mechanisms underlying endometriosis and depression association is lacking. 
With a twin-based heritability (the proportion of variance in phenotypes explained by variance 
in genotype) estimate of about 0.50 and single nucleotide polymorphism (SNP)-based 
heritability of 0.26, there is strong evidence for a role of genetic factors in the risk of 
endometriosis (Kennedy 1999; Lee et al. 2012; Montgomery et al. 2008; Simpson and Bischoff 
2002; Stefansson et al. 2002). Similarly, consistent evidence supports the contribution of 
genetics in the development of depression (Levinson 2006; Ripke et al. 2013), with a twin-
based heritability estimate of 0.31–0.42 (Sullivan et al. 2000). Indeed, several genome-wide 
association studies (GWAS) have been conducted and an increasing number of SNPs, as well 
as susceptibility loci, are being identified for both endometriosis and depression (Howard et al. 
2019; Sapkota et al. 2017; Wray et al. 2018). No study has, however, leveraged on the possible 
pleiotropy of genetic variants among the two disorders as a basis for the discovery of new 
susceptibility loci shared by both endometriosis and depression. Furthermore, studies with a 
specific focus on the mechanism of association between endometriosis and depression, using 
the molecular genetic study approach, are lacking. 
Therefore, we comprehensively assessed the genetic relationship between endometriosis and 
depression by analyzing large population-based GWAS data. The approaches used in this study 
minimize the challenges often associated with the conventional observational studies such as 
small sample sizes, the bias of reverse causation and the confounding influence of 
environments or lifestyles. Moreover, analysis of such molecular genetic data offers a unique 
opportunity to assess not only the shared genetics but also the potential causal associations 
between the two traits. Hence, findings in the present study will improve our understanding of 
the genetic architecture of the two disorders, as well as provide insights into the mechanisms 
of their co-occurrence. This knowledge is expected to contribute to efforts aimed at identifying 




Materials and Methods 
Our study comprises five broad components. First, we assessed the molecular genetic overlap 
and correlation between endometriosis and depression using SNP effect concordance analysis 
(SECA) and linkage disequilibrium score regression (LDSC) analysis methods, respectively. 
Second, leveraging on the power afforded by pooling GWAS data, we investigated SNPs and 
loci shared by the two traits using cross-disorder meta-analysis of GWAS. Third, utilizing 
Mendelian randomization (MR), we assessed potential causal relationships between 
endometriosis and depression. Fourth, to identify genes shared by endometriosis and 
depression as well as assess gene-level genetic overlap, we performed gene-based association 
studies and independent gene-based test. Lastly, to gain mechanistic insights into the biology 
of the two disorders, we investigated biological pathways shared by endometriosis and 
depression using pathway-based functional enrichment analysis method.  
Data sources 
GWAS summary statistics data sourced from large international consortia including the 
International Endogene Consortium (IEC, endometriosis GWAS data) (Sapkota et al. 2017) 
and the Psychiatric Genomics Consortium (PGC, PGC_UKB depression GWAS data) were 
utilized for analyses in the present study. There is no sample overlap between these two GWAS 
data; hence, limitations associated with overlap of samples do not apply in our study. 
IEC Endometriosis GWAS data 
The ‘IEC endometriosis’ GWAS summary statistics data analyzed in this study have been well 
described in previous studies (Adewuyi et al. 2020; Sapkota et al. 2017). In brief, the data 
consist of a total sample of 208,912 individuals (17,054 cases of endometriosis and 191,858 
controls), and 6,979,035 SNPs (that passed quality control in at least 50% of the studies), 
representing the largest GWAS published to date in the genetic study of endometriosis (Sapkota 
et al. 2017). The ‘IEC endometriosis’ GWAS data combined 11 separate GWA case-control 
data sets as previously described in Sapkota et al. (2017). Similar quality control (QC) 
procedures were applied in each of the individual datasets and study participants were of 
European (93%) and Japanese (7%) ancestry from Australia, Iceland, Belgium, the UK, the 





Depression GWAS data 
The ‘2019 PGC_UKB Depression Genome-wide’ summary data (‘PGC_UKB depression’ 
GWAS data) analyzed in our study were obtained from the PGC 
(https://www.med.unc.edu/pgc/). The ‘PGC_UKB depression’ GWAS combines two large 
depression data sourced from the PGC and the United Kingdom Biobank (UKB). The PGC 
components of the data comprise of a meta-analysis of 33 cohorts (excluding the 23andMe and 
the UKB data) and have been previously described (Wray et al. 2018). The second component 
of the ‘PGC_UKB depression’ GWAS data was obtained from the UKB broad depression 
phenotype described in (Howard et al. 2019). Together, the PGC_UKB depression’ GWAS 
data consist of a total sample of 500,199 individuals (170,756 cases of depression and 329,443 
controls), of European ancestry, and a total of 8,483,301 SNPs. 
To test the reproducibility of our study, we utilized two additional depression datasets—the 
2018 major depressive disorder (MDD) GWAS and the self-reported depression GWAS, 
sourced from the PGC and the UKB, respectively. The 2018 MDD GWAS comprised of 
135,458 cases and 344,901 controls (Wray et al. 2018). Of these, 75,607 cases and 231,747 
controls were obtained from 23andMe. The data utilized in the present study (the ‘PGC 2018 
MDD excl23andMe’) excluded the 23andMe data (to avoid sample overlap with the IEC 
endometriosis GWAS) and consisted of 59,851 cases, 113,154 controls, and a total of 
13,554,551 SNPs. A more comprehensive description of the data has previously been published 
(Wray et al. 2018). The self-reported depression UKB GWAS data 
(https://atlas.ctglab.nl/ukb2_sumstats/20002_1286_logistic.EUR.sumstats.MACfilt.txt.gz) 
consist of 289,307 individuals (cases = 22,055, control = 267,252) and 10,321,706 SNPs. 
Assessing SNP-level genetic overlap 
We assessed the SNP-level genetic overlap between endometriosis and depression using the 
standalone version of SECA (https://sites.google.com/site/qutsgel/software/seca-local-
version) (Nyholt 2014). We used the default ‘P value informed’ setting of SECA to extract the 
subset of independent SNPs overlapping the two GWAS datasets accounting for linkage 
disequilibrium (LD) r2 < 0.1. We first assigned the ‘IEC endometriosis’ GWAS as dataset 1 
and the ‘PGC_UKB depression’ GWAS as dataset 2 to extract the set of independent SNPs 
with the smallest endometriosis GWAS P values. We performed an analogous analysis in 
which the ‘PGC_UKB depression’ GWAS was assigned as dataset 1 and the ‘IEC 
endometriosis’ GWAS as dataset 2 to analyze the set of independent SNPs with the smallest 
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depression GWAS P values. This procedure enabled us to assess and allow for possible 
differences between the two GWAS to detect association at their overlapping SNPs or where 
one trait may be more predictive of the other (Adewuyi et al. 2020; Nyholt 2014). Last, we 
utilized the ‘PGC 2018 MDD excl23andMe’ and the ‘self-reported depression UKB’ GWAS 
in reproducibility testing for the SNP-level genetic overlap between endometriosis and 
depression. A more comprehensive description of our SNP-level genetic overlap assessment is 
presented in Supplemental Note 1.  
Cross-disorder genetic correlation  
We estimated the SNP-based heritability as well as examined the genetic correlation between 
the ‘IEC endometriosis’ GWAS and the ‘PGC_UKB depression’ GWAS, using the LDSC 
method (https://github.com/bulik/ldsc) (Bulik-Sullivan et al. 2015). We performed further 
analyses to test the reproducibility of the genetic correlation between endometriosis and 
depression using two additional GWAS datasets, the ‘PGC 2018 MDD excl23andMe’ and the 
‘self-reported depression UKB’ GWAS. Supplemental Note 1 provides more comprehensive 
and specific details of this analysis.  
Cross-disorder meta-analysis of endometriosis and depression GWAS 
To identify SNPs and loci shared by both endometriosis and depression, we performed a cross-
disorder meta-analysis of ‘IEC endometriosis’ and the ‘PGC_UKB depression’ GWAS data. 
Complementary models of meta-analysis methods including the inverse variance-weighted 
fixed effects (FE), the conventional random effects (RE) and the ‘Han and Eskin’s random 
effects’ (RE2) models (Han and Eskin 2011) were utilized in the present study. The FE model 
is limited under heterogeneity while the RE is overly conservative. The RE2, a modified RE 
model, is optimized for detecting associations even where heterogeneity exists (Han and Eskin 
2011). All these models were implemented in the METASOFT software 
(http://genetics.cs.ucla.edu/meta) (Han and Eskin 2011). We included a total of 709,111 
participants and meta-analyzed 6,694,342 SNPs overlapping the two GWAS datasets. 
Identifying SNPs and loci reaching genome-wide significant association (P < 5 × 10-8) in the 
meta-analysis, and, associated with both endometriosis and depression GWAS at 5 × 10-8 < P 
< 0.05, was the major aim of the present analysis.  
Using FUMA (Watanabe et al. 2017), we identified significant independent SNPs alongside 
SNPs in LD with them, defined lead SNPs as well as characterized the associated genomic loci 
(r2 < 0.1). SNPs reaching genome-wide significant association (P < 5 × 10-8, n = 625) in the 
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cross-disorder meta-analysis but not in the individual endometriosis and depression GWAS (5 
× 10-8 < P < 0.05) were used for this analysis. We first identified genome-wide significant 
independent SNPs at r2 < 0.6 (that is SNPs that are independent of one another at r2 < 0.6). 
From these, lead SNPs, defined as a subset of significant independent SNPs in LD with each 
other at r2 < 0.1, were determined. Genomic loci were thereafter characterized with respect to 
a physical distance of 250 kb from each lead SNP. In other words, lead SNPs within 250 kb 
from each other were merged into the same genomic locus. Hence, more than one independent 
or lead SNP may be present in a genomic locus.  
Further, we performed gene mapping in which all the SNPs reaching genome-wide significance 
were mapped to genes using three gene mapping strategies, implemented in FUMA (Watanabe 
et al. 2017). Briefly, SNPs were first annotated with their biological functions and subsequently 
linked to genes using the three methods (positional, expression quantitative trait loci [eQTL], 
and chromatin interaction) in line with practice in previous studies (Nagel et al. 2018; 
Watanabe et al. 2017). Additionally, we performed a gene-based genome-wide association 
study (GBGWAS) on the same set of SNPs using MAGMA software (implemented in FUMA). 
A detailed description of our cross-disorder meta-analysis, genomic loci characterization, SNP 
annotation, and functional gene mapping is provided in Supplemental Note 1. 
Association between significant independent SNPs and other traits 
We assessed a possible SNP-phenotype association between our independent genome-wide 
significant SNPs and other previously published GWAS traits. Specifically, we assessed 
whether our independent SNPs were associated with traits previously reported to be associated 
with endometriosis or depression. This assessment was carried out using PhenoScanner (v2, 
accessed on 07/01/2020) at P < 5 × 10-8) (Staley et al. 2016). 
Assessing causal relationships between endometriosis and depression 
We assessed  a causal relationship between endometriosis (exposure variable) and depression 
(outcome variable) utilizing the two-sample Mendelian randomization analysis 
(“TwoSampleMR”) method (https://mrcieu.github.io/TwoSampleMR) (Hemani et al. 2018) 
implemented in the R statistical software. To estimate the weighted mean of depression risk 
per standard deviation increase in the risk of endometriosis, we utilized the inverse variance 
weighted (IVW) MR model in which the effects of the individual IVs were combined (Burgess 
et al. 2020). To test the validity of our IVW results, we conducted sensitivity analyses using 
the weighted median estimation, the MR-Egger regression, and the MR-PRESSO (Mendelian 
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randomization pleiotropy residual sum and outlier) methods (Verbanck et al. 2018). We also 
assessed the causal influence of depression on endometriosis in which depression was assessed 
as an exposure variable and endometriosis as an outcome variable. Additional details of these 
analyses are provided in Supplemental Note 1. 
Gene-based association study 
To complement our SNP-level genetic overlap analysis across endometriosis and depression 
GWAS, and identify genes shared by the two disorders, we performed gene-based association 
analyses for the two traits. Unlike the SNP-based study which can be limited by small effect 
sizes, allelic heterogeneity and correlation among SNPs, gene-level association analysis 
aggregates the effects of multiple SNPs and may provide greater power for identifying risk 
variants for a complex trait (Liu et al. 2010; Zhao and Nyholt 2017). The MAGMA software, 
implemented in FUMA, was used to perform this analysis (de Leeuw et al. 2015; Watanabe et 
al. 2017). A total of 6,694,342 SNPs overlapping the endometriosis and depression GWAS was 
used in computing gene-based P values for the respective traits. SNPs were mapped in 
MAGMA to a gene if they were located within the gene (i.e., a window of ‘+/- 0kb outside the 
gene’) in our analysis. From the results of our MAGMA analysis, we extracted and assessed 
genes with P values at Pgene < 0.1 overlapping both traits. To identify shared genome-wide 
significant genes for both endometriosis and depression, we combined gene-based association 
P values for the two disorders using the Fisher’s Combined P value (FCP) method.  
Independent gene-based test 
Using the genetic type 1 error calculator (GEC) (Li et al. 2012), we conducted independent 
gene-based tests, first to identify the effective number of independent genes, and second to 
generate data for assessing the gene-level genetic overlap between endometriosis and 
depression. GEC estimates independent markers while accounting for LD and adjusting for 
multiple testing corrections (Li et al. 2012). We first performed a gene-based test for 
endometriosis and depression using VEGAS2 software. We used ‘ALL’ chromosomes, 
restricted gene definition to ‘+/- 0kb outside gene’ and selected sub-population from ‘ALL 
EUROPEAN’ in our VEGAS2 gene-based analysis (Adewuyi et al. 2020; Mishra and 
Macgregor 2015). Given our aim of performing an independent gene-based test, we specified 
the ‘Best-SNP test’ option in our VEGAS2 gene-based analysis (Adewuyi et al. 2020; Mishra 
and Macgregor 2015). We processed ‘Best-SNPs’ (index SNPs) obtained in our gene-based 
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analysis, for endometriosis and depression, respectively, as input files for GEC. See 
Supplemental Note 1 for further details of this analysis.  
Assessing gene-level genetic overlap 
We assessed whether the proportion of overlapping genes, between endometriosis and 
depression, at three nominal P values (Pgene < 0.1, Pgene < 0.05, and Pgene < 0.01) thresholds, 
were more than expected by chance. The independent gene-based analyses results were utilized 
for this analysis. First, we estimated the effective number of independent genes overlapping 
endometriosis and depression at the three-nominal P values. Second, we assigned 
endometriosis as the ‘discovery’ and depression as the ‘target’ set; and thereafter, calculated 
the proportion of expected as well as observed genes overlapping the two traits. Last, using the 
binomial test, we compared the proportion of observed and expected overlapping independent 
genes across the three P value thresholds to assess the statistical significance of their respective 
differences. In other words, we assessed whether the proportion of overlapping genes observed 
were significantly higher than by chance. The expected proportion of overlapping genes was 
defined as the effective number of independent genes with a P value less than the threshold in 
the target set divided by the total effective number of independent genes in the target set 
(Adewuyi et al. 2020; Zhao et al. 2016). The observed proportion of overlapping genes was 
calculated as the observed effective number of independent overlapping genes divided by the 
effective number of independent genes with a P value less than the threshold in the discovery 
set (Adewuyi et al. 2020; Zhao et al. 2016). 
Gene-drug targets search 
We searched for ‘gene-drug interactions’ and ‘potential targets for drugs’ using the drug-gene 
interaction database (DGIdb 3.0, www.dgidb.org, accessed on 24/12/2019) (Cotto et al. 2017; 
Griffith et al. 2013). Utilizing genes overlapping endometriosis and depression at Pgene < 0.1 , 
we first searched 20 DGIdb drug-gene source databases to identify interactions with existing 
medicines based on 41 gene categories and 51 types of known interactions. We filtered drugs 
that interact with our input genes using the following terms or categories: antineoplastic, 
immunotherapies and the United States Food and Drug Administration (FDA) approved 
pharmaceutical molecules. Moreover, to identify genes for potential therapeutic targets 
(druggable targets), we conducted a further search in 10 source databases (implemented in the 
DGIdb tool), based on 41 gene categories. A list of overlapping genes having Pgene < 0.1 were 
similarly used as an input in the druggable targets search.  
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Pathway-based functional enrichment analysis  
We conducted functional enrichment analysis using the ‘g:GOSt’ tool, implemented in the ‘g-
profiler’ software (Raudvere et al. 2019; Reimand et al. 2016), to identify significantly enriched 
(overrepresented) biological processes and pathways underlying endometriosis and depression. 
We utilized the web version of the ‘g:GOSt’ tool (accessed on 15th December 2019) to analyze 
genes overlapping endometriosis and depression GWAS at Pgene < 0.1, in the present study. We 
applied the recommended ‘g:SCS algorithm’ in multiple testing correction and restricted term 
size (functional category) of the significantly enriched pathways to the recommended 5 and 
350 values (Adewuyi et al. 2020; Raudvere et al. 2019). By default, the ‘g:GOSt’ software only 
reports overrepresented pathways at the adjusted enrichment P value (Padj) < 0.05 (Raudvere 
et al. 2019). Given some of the significantly enriched pathways may be redundant, we carried 
out enrichment mapping, collapsing related pathways into similar biological themes, and 
subsequently enhancing the visualization of overrepresented pathways (Merico et al. 2010; 
Reimand et al. 2019). Lastly, to further enhance the interpretation of our results, we organized 
‘enrichment maps’ (biological themes of pathways generated using the ‘enrichment mapping’ 
method) into clusters using the ‘auto annotate’ software (Reimand et al. 2019). The 
‘enrichmentmap’ and ‘auto-annotate’ applications were implemented in the Cytoscape 
platform (version 3.7.1) (Reimand et al. 2019; Shannon et al. 2003). 
Results 
SNP-level genetic overlap between endometriosis and depression 
The first aspect of this study assessed SNP-level genetic overlap between the endometriosis 
and depression GWAS utilizing SECA. Results indicate that a significant genetic overlap, more 
than expected by chance, exists between endometriosis and depression. In the primary test for 
concordance of effects, all 144 SNP subsets across ‘IEC endometriosis’ and ‘PGC_UKB 
depression’ GWAS produced nominally significant concordance of effects (Fisher’s exact test 
OR > 1 and P < 0.05)—a result unlikely to have occurred by chance, with a permuted P value 
(PFsig-permuted) of 9.99 × 10-4 (95%CI: 5.12 × 10-5–5.64 × 10-3). The most statistically significant 
P value for effects concordance (P = 1.04 × 10-19, ORFT = 1.31) was for SNP subsets with P1 
≤ 0.3 (endometriosis) and P2 ≤ 0.4 (depression). When the direction of the analysis was 
reversed (see methods), the total number of SNP subsets producing nominally significant 
concordance effects remained unchanged at 144, further supporting our findings of significant 
genetic overlap between the two traits.  
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Additional results from SECA reveal that of the total 50,413 independent SNPs (LD 
independent [r2 < 0.1]) overlapping both the IEC Endometriosis and the PGC-UKB depression 
GWAS, 26,102 (51.8%) SNP effects were significantly concordant across the two traits (OR = 
1.13, PFisher’s-exact = 1.36 × 10-11). Notably, and in line with expectation (Table 1), SNP subsets 
with smaller P values (P1 and P2) exhibit even greater effect concordance (measured by OR). 
For instance, at P < 0.05 (SNP subsets with P1 = P2 < 0.05), 57.8% (1,065) of the 1,844 
independent SNPs were concordant (OR = 1.86, PFisher’s-exact = 4.72 × 10-11). The proportion of 
effect concordance increased to 66.7% for SNP subsets with P1 = P2 < 0.01 (OR = 3.98, 
PFisher’s-exact = 2.67 × 10-7). Reproducibility testing using two separate depression GWAS (the 
MDD 2018 and the self-reported UKB depression GWAS) revealed a similar pattern of results 
(Supplementary Table S1 and S2). For example, at P1 = P2 < 0.01 (for the ‘IEC endometriosis’ 
and the ‘PGC 2018 MDD excl23andMe’ GWAS genetic overlap assessment), the OR was 3.95 
(PFisher’s-exact = 3.28 × 10-4). Similarly, OR was 3.27 (PFisher’s-exact = 2.14 × 10-3) for the genetic 
overlap between the ‘IEC endometriosis’ and the ‘self-reported UKB depression’ at P1 = P2 < 
0.01 (Supplementary Table S1 and S2).  
Table 1 Genetic overlap between endometriosis and depression 







≤1 ≤1 50,413 26,102 0.52 1.13 1.36 × 10-11 
0.9 0.9 45,446 23,502 0.52 1.15 2.88 × 10-13 
0.8 0.8 40,343 20,939 0.52 1.17 2.20 × 10-14 
0.7 0.7 35,086 18,339 0.52 1.20 2.07 × 10-17 
0.6 0.6 29,807 15,656 0.52 1.22 3.27 × 10-18 
0.5 0.5 24,608 12,977 0.53 1.24 1.16 × 10-17 
0.4 0.4 19,416 10,313 0.53 1.28 4.81 × 10-18 
0.3 0.3 14,178 7,596 0.54 1.33 1.85 × 10-17 
0.2 0.2 9,022 4,877 0.54 1.38 1.47 × 10-14 
0.1 0.1 4,049 2,252 0.56 1.57 9.13 × 10-13 
0.05 0.05 1,844 1,065 0.58 1.86 4.72 × 10-11 
0.01 0.01 246 164 0.67 3.98 2.67 × 10-7 
P1: P value for the International Endogene Consortium (IEC) Endometriosis data; P2: P value for the PGC-UKB 
depression data; SNP: Single Nucleotide Polymorphism; OR: Odds ratio for the effect direction concordance 
association test for endometriosis and depression; PFishers-exact: Fisher’s exact P value for the effect direction 
concordance association test between endometriosis and depression. aThere was a total 50,413 independent SNPs 








Genetic correlation between endometriosis and depression 
To further assess the SNP-level genetic overlap between endometriosis and depression GWAS, 
we examined the correlation between endometriosis and depression using the LDSC software. 
Univariate LDSC analysis estimated SNP-based heritability on the liability scale (h2SNP) of 
11.44% (95%CI: 10.73–12.15%) for endometriosis and 8.02% (95%CI: 7.77–8.27%) for 
depression. Also, bivariate LDSC analysis found a positive and highly significant genetic 
correlation (rG) between endometriosis and depression (rG = 0.27, P = 8.85 × 10-27). LDSC 
results are provided in Table 2. Notably, we reproduced the significant genetic correlation 
between endometriosis and depression using two separate depression GWAS (Table 2). 
Table 2 LD Score regression analysis summary 
A. SNP-based Heritability 
Phenotype Dataset source Liability scale h2SNP (95% 
CI) 
h2 Intercept (se) 
Endometriosis IEC 11.44% (10.73–12.15%) Constrained to 1 
PGC-UKB depression PGC-UKB 2019 8.02% (7.77–8.27%) Constrained to 1 
MDD PGC 2018 6.93% (6.64–7.22%) 0.9945 (0.0087) 
Depression UKB 8.25% (7.08–9.41%) Constrained to 1 
 
B. SNP-based Genetic Correlation 


























MDD (PGC 2018) 0.28 (0.0321) 









Depression (UKB) 0.21 (0.0476) 





IEC: International Endogene Consortium, PGC: Psychiatric Genomic Consortium, UKB: United Kingdom 
BioBank, SNP: Single Nucleotide Polymorphism, h2: heritability, h2SNP: SNP-based heritability, CI: Confidence 
Interval, se: Standard error 
 
GWAS meta-analysis results 
We performed a cross-disorder meta-analysis of endometriosis and depression GWAS to 
identify genome-wide significant SNPs and loci shared by both traits. A total of 625 SNPs was 
significant (PSNP < 5×10−8) in the FE model of our cross-disorder meta-analysis 
(Supplementary Table S3), all of which were at least nominally significant (P < 0.05), but not 
genome-wide significant in the individual endometriosis and depression GWAS (i.e., 5 × 10-8 
< P < 0.05). From the 625 SNPs reaching genome-wide significant association, we identified 
34 moderately independent (LD r2 < 0.6) SNPs (Table 3A). Of these 34 SNPs, 22 were 
characterized as lead SNPs (genome-wide significant SNPs that are independent of one another 
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at LD r2 < 0.1). A total of 20 independent genomic loci were characterized as having lead SNPs 
at least 250 kb from another lead SNP (i.e., lead SNPs within 250 kb from each other were 
merged into the same genomic locus). Thus, the 22 lead SNPs were in 20 genomic loci, with 
two loci containing two independent lead SNPs each. Eight of the 20 independent genomic loci 
have not previously been reported at a genome-wide level of significance for endometriosis or 










Lead SNP Chr Position 
(hg19) 
EA NEA FE Meta-analysis Endometriosis Depression Nearest coding 
gene/ cytoband OR P value OR P value OR P value 
A. Summary of ‘IEC endometriosis’ and ‘PGC-UKB depression’ GWAS meta-analysis 
Loci linked with depression index SNPs 
rs1395455 1 rs1395455 1 37185190 A G 1.025 4.09 × 10-8 1.03 4.05 × 10-2 1.024 2.92 × 10-7 CSF3R/ 1p34.3 










1 197470756 A T 0.971 1.17 × 10-8 0.961 2.81 × 10-2 0.972 1.01 × 10-7 CRB1/1q31.3 
rs1998711 1 197546093 A T 0.976 1.87 × 10-9 0.947 6.93 × 10-5 0.979 4.96 × 10-7 DENND1B/1q31.3 
rs12121863 1 197785420 A G 1.033 3.54 × 10-10 1.065 2.22 × 10-4 1.030 8.22 × 10-8 DENND1B/1q31.3  
rs1553172 1 197818233 A G 1.023 4.62 × 10-8 1.053 1.57 × 10-4 1.020 6.47 × 10-6 C1orf53/1q31.3 








3 49206767 T C 0.976 1.84 × 10-8 0.952 5.87 × 10-4 0.978 1.22 × 10-6 KLHDC8B/3p21.31  
rs9586 3 49213637 T C 0.969 2.36 × 10-10 0.939 1.24 × 10-4 0.972 5.06 × 10-8 KLHDC8B/3p21.31 
rs9835157 3 49797769 A G 1.034 3.80 × 10-10 1.067 2.92 × 10-4 1.031 6.58 × 10-8 IP6K1/3p21.31 
rs12512642 5 rs12512642 4 131209887 T C 1.028 4.93 × 10-8 1.044 2.71 × 10-2 1.027 3.48 × 10-7 SCLT1/ 4q28.2 









6 66559858 A C 0.974 4.77 × 10-9 0.968 2.46 × 10-2 0.975 5.75 × 10-8 EYS/6q12 
rs9885896 6 66595931 A G 0.976 3.53 × 10-9 0.960 2.14 × 10-3 0.978 2.00 × 10-7 EYS/6q12 
rs4710557 6 66623210 C G 1.029 1.43 × 10-8 1.040 1.92 × 10-2 1.027 1.49 × 10-7 EYS/6q12 
rs767069 6 66646546 A G 1.025 7.31 × 10-9 1.030 3.50 × 10-2 1.025 8.01 × 10-8 EYS/6q12 
rs12206488 6 66999917 T G 1.031 2.23 × 10-9 1.047 7.67 × 10-3 1.029 5.12 × 10-8 EYS/6q12 
rs2328370 8 rs2328370 6 143006706 A C 1.023 3.21 × 10-8 1.031 2.55 × 10-2 1.023 2.48 × 10-7 HIVEP2/6q24.2 







9 11120126 T G 1.031 3.99 × 10-8 1.039 4.19 × 10-2 1.030 2.72 × 10-7 PTPRD/ 9p24.1-p23 
rs1931391 9 11213674 A T 1.025 8.32 × 10-9 1.027 4.92 × 10-2 1.024 6.61 × 10-8 PTPRD/9p24.1-p23 
rs62553458 9 11695224 A G 0.951 9.48 × 10-9 0.934 4.65 × 10-2 0.952 6.28 × 10-8 TYRP1/9p23 
rs13299293 11 rs13299293 9 31234705 A T 0.976 2.03 × 10-9 0.961 8.33 × 10-3 0.977 5.31 × 10-7 ACO1/ 9p21.1 
rs5021654   11 88910589 C G 1.024 7.96 × 10-9 1.033 1.77 × 10-2 1.024 1.10 × 10-7 TYR/11q14.3 
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rs7933594 12 rs7933594 
 
11 88973201 T C 1.026 5.67 × 10-9 1.031 3.60 × 10-2 1.026 4.10 × 10-8 TYR/11q14.3 
rs1967203 11 89055293 A G 0.977 3.73 × 10-8 0.966 2.19 × 10-2 0.978 5.56 × 10-7 TYR/11q14.3 
Novel Loci 
rs6680839 13 rs6680839 1 175902596 T C 0.975 9.18 × 10-10 0.952 5.24 × 10-4 0.977 1.25 × 10-7 TNR/1q25.1 
rs72740410 14 rs72740410 1 191115099 T C 1.048 1.25 × 10-8 1.049 7.44 × 10-2 1.048 6.65 × 10-8 BRINP3/1q31.1 
rs13118306 15 rs13118306 4 15477812 C G 0.977 3.65 × 10-8 0.960 3.76 × 10-3 0.979 1.21 × 10-6 CC2D2A/4p15.32 
rs2134025 16 rs2134025 4 104932297 A G 1.029 1.02 × 10-8 1.057 4.12 × 10-4 1.026 1.31 × 10-6 TACR3/4q24 
rs9347896 17 rs9347896 6 165077749 A G 1.029 1.32 × 10-8 1.033 4.56 × 10-2 1.028 7.80 × 10-8 C6orf118/6q27 
rs11784932 18 rs11784932 8 130095478 A C 1.026 2.82 × 10-8 1.057 2.57 × 10-4 1.023 3.25 × 10-6 GSDMC/ 8q24.21 
rs9538160 19 rs9538160 13 59254159 A G 0.976 2.71 × 10-8 0.964 8.96 × 10-3 0.978 5.17 × 10-7 PCDH17/ 13q21.1 
rs35625885 20 rs35625885 15 96957969 A G 0.965 1.33 × 10-8 0.953 2.04 × 10-2 0.966 2.10 × 10-7 NR2F2/15q26.2 
 
B. Summary of the meta-analysis of ‘IEC endometriosis’ and ‘PGC 2018 MDD excluding 23andME’ GWAS 
rs6808036 1 rs6808036 3 49236439 T G  1.044 2.49 × 10-8 1.065 4.31 × 10-5 1.037 4.52 × 10-5 CCDC36/ 3p21.31 
rs323509 2 rs323509 5 104082179 A C  1.042 2.15 × 10-8 1.031 3.68 × 10-2 1.046 1.45 × 10-7 NUDT12/ 5q21.2 
rs116810322 3 rs116810322 6 30223490 T C  1.042 9.70 × 10-9 1.064 4.79 × 10-5 1.036 1.47 × 10-5 TRIM26/ 6p22.1 
rs1931388 4 rs1931388 9 11203149 A G  1.039 4.44 × 10-8 1.030 3.91 × 10-2 1.042 3.01 × 10-7 PTPRD/ 9p24.1-
p23 
 
C. Summary of the meta-analysis of ‘IEC endometriosis’ and ‘UKB self-reported depression’ GWAS 
rs6788293 1 rs6788293 3 13719848 T C  0.952 2.81 × 10-8* 0.931 1.30 × 10-7 0.972 4.75 × 10-3 LINC00620/ 3p25.1 
FE: Fixed effect; SNP: Single nucleotide polymorphism; Chr: Chromosome; EA: Effect allele; NEA: Non-effect allele; OR: Odds ratio. *RE2 model result reported (Table 3C) 
due to the substantial heterogeneity (I Square = 84.59). Of the 34 independent SNPs (r2 < 0.6) reported in Table 3A, a total of 22 are independent from each other at r2 < 0.1 
(lead SNPs). Using physical regions in LD with lead SNPs that were >250 kb from each other, 20 genomic loci were characterized from the 34 independent SNPs. Lead SNPs 




Our functional annotation analysis using FUMA (see methods), identified a total of 2,372 
candidate SNPs (independent SNPs as well as those in LD with them at  r2 ≥ 0.6), and 22 lead 
SNPs (genome-wide significant SNPs that are independent of one another at LD r2 < 0.1). Most 
of the candidate SNPs were in the intergenic (66.30%), intronic (25.40%) and non-coding RNA 
(4.91%) regions (Supplementary Fig. 1a, and Supplementary Table S4). As evidenced by 
RegulomeDB scores having values less than two (Supplementary Fig. 1b and Supplementary 
Table S4), a total of 75 SNPs (3.20% of candidate SNPs) has a high likelihood of a regulatory 
function. Of the eleven exonic SNPs, six were synonymous while five were nonsynonymous 
(Supplementary Fig. 1a, and Supplementary Table S4 and S5). Several of the SNPs had a 
CADD score greater than 12.37 (Supplementary Fig. 1c) meaning they are potentially 
pathogenic. The nonsynonymous exonic SNP having the highest CADD score (an indication 
of strong deleterious effects) was rs1126809 (CADD score of 29.4). This SNP is located in 
exon 4 of TYR on chromosome 11 and it is in strong LD with a lead SNP (rs7933594, r2 = 
0.72), located at a genomic locus in LD with a depression index SNP (Table 3 and 
Supplementary Table S4).  
Using three methods of gene mapping strategies, implemented in FUMA—positional, 
expression quantitative trait locus (eQTL), and chromatin interaction—we mapped the 
candidate SNPs to genes (see methods). Additionally, we carried out GBGWAS on the same 
set of SNPs using MAGMA software (implemented in FUMA). A total of 223 unique protein-
coding genes was implicated, 20 of which were identified by all four methods (Supplementary 
Fig. 2, Supplementary Table S6, S7 and S8). A total of 49 genes were implicated by positional 
mapping, 73 by eQTL, and 217 by chromatin interaction mappings (Supplementary Fig. 2). 
GBGWAS analysis identified a total of 24 genome-wide significant genes (Supplementary Fig. 
2 and Supplementary Table S7 and S8). Furthermore, we characterized a total of 90 
independent loci reaching genome-wide suggestive association (P < 1 × 10-5) in the cross-
disorder meta-analysis of the IEC endometriosis and the PGC-UKB depression GWAS 
(Supplementary Table S9). 
Association between significant independent SNPs and other traits 
Using PhenoScanner (v2), with an LD and significant threshold of r2 ≥ 0.6 and P < 5 × 10-8, 
respectively (Staley et al. 2016), we assessed whether the independent genome-wide significant 
SNPs identified in our meta-analysis were associated with other traits or conditions. Findings 
revealed a genome-wide significant (P < 5 × 10-8) association with several traits 
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(Supplementary Table S10). Notably, one of the independent significant SNPs, rs9835157 
(hg19: chr3:49797769 A>G on chromosome 3p21.31) in IP6K1 (encoding inositol 
hexakisphosphate kinase 1), was associated with several traits at a genome-wide significant 
level (P < 5 × 10-8), including qualifications (college or university degree), age at menarche, 
body mass index, pulse rate, impedance of the whole body, and overall health rating. One of 
these traits (age at menarche) is a risk factor for endometriosis (Nnoaham et al. 2012) and 
depression (Shen et al. 2019). Also, neuroticism (a possible risk factor for both endometriosis 
and depression) (Nyholt et al. 2009; Xia et al. 2011) was associated with one of the SNPs 
(rs62553458, hg19: chr9:11695224A>G). Lastly, rs13164188 (on chromosome5q21.2) was 
associated at a genome-wide significant level with waist circumference, hearing difficulty, as 
well as a doctor diagnosed ‘bronchitis, emphysema, asthma, rhinitis, eczema or allergy’. 
Replication of identified loci 
To test whether the independent loci reaching genome-wide significance in our meta-analysis 
(for IEC endometriosis and PGC-UKB depression GWAS) can be replicated, we conducted 
additional meta-analyses using the ‘PGC 2018 MDD excl23andMe’ and the ‘self-reported 
depression UKB’ GWAS. Using the lead SNPs, we considered a locus reproduced when the P 
value obtained in a cross-disorder meta-analysis (P [FE] or P [RE2]) is less than the respective P 
value for each of endometriosis and depression GWAS. The P value for each of endometriosis 
and depression GWAS must at the least be nominally significant (P < 0.05). 
First, a meta-analysis of the ‘IEC endometriosis’ and the ‘PGC 2018 MDD excl23andMe’ 
reproduced 17 of the 20 independent loci at P < 0.05 (Supplementary Table S11). Although 
none of the loci reached genome-wide significant association, seven of them (rs9586 on 
chromosome 3p21.31, rs2134025 on 4q24, rs13164188 on 5q21.2, rs11561993 on 7q31.1, 
rs11784932 on 8q24.21, rs1931391 on 9p24.1-p23, and rs13299293 on 9p21.1) were genome-
wide suggestive (P < 1 × 10-5, Supplementary Table S11). Also, additional four independent 
loci reached a genome-wide level of significance in the replication analysis (Table 3B), all  
(rs323509, rs1931388, rs116810322, rs1931388) of which have been identified in more 
powerful depression GWAS to be genome-wide significant (Howard et al. 2019; Nagel et al. 
2018). 
Second, meta-analyzing the ‘IEC endometriosis’ and the ‘self-reported depression UKB’ 
GWAS, we similarly reproduced 6 of the 20 loci at P < 0.05. Of these, two loci (rs12121863 
on chromosome 1q31.3, and rs9586 on 3p21.31) were at least genome-wide suggestive 
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(Supplementary Table S12). Also, we identified an additional independent SNP locus shared 
by both endometriosis and depression (Table 3C). 
Results of causal associations assessment  
Table 4 summarizes the results of our MR analyses assessing the causal association between 
endometriosis and depression. Based on the IVW MR model (OR = 1.003, 95%CI: 0.967–
1.041, P = 0.866), MR did not find evidence of a significant causal relationship between 
endometriosis (exposure variable) and depression (outcome variable). The results of our 
sensitivity analysis using the weighted median (OR = 1.018, 95%CI: 0.979–1.059, P = 0.371) 
and the MR Egger (OR = 1.134, 95%CI: 0.925–1.390, P = 0.258) models were consistent with 
that of the IVW in this respect (Table 4). The MR-Egger intercept was -0.0123 (SE: 0.0104), 
P = 0.262, which did not deviate significantly from zero, showing that there was no significant 
directional or unbalanced pleiotropy. Also, given the Cochran’s Q statistics for IVW (Q = 
17.23, degree of freedom, df = 10, P = 0.069) and MR-Egger (Q’ = 14.87, df = 9, P = 0.095), 
there was no evidence for a significant heterogeneity. One of the SNPs (rs74485684) was 
associated with menstruation-related traits (‘length of menstrual cycle’ and ‘excessive, 
frequent and irregular menstruation’). However, a leave-one-out analysis indicates that 
individual influential SNPs did not drive the observed results. A further assessment using the 
MR-PRESSO method supports the IVW model. For instance, MR-PRESSO’s raw estimate was 
similar to that of the IVW (Table 4). Also, the ‘global test’ found no significant horizontal 
pleiotropy (global test P value = 0.0758) just as the ‘outlier test’ found no outlier SNPs. 
In contrast, analysis for a causal influence of depression (exposure variable) on endometriosis 
(outcome variable) using the IVW model provided evidence of a causal association between 
the two traits (OR = 1.26, 95%CI: 1.046–1.51, P = 0.0149). A sensitivity assessment using the 
weighted median model supports this finding (OR = 1.24, 95%CI: 1.012–1.55, P = 0.0447); 
however, the MR-Egger method did not (OR = 1.069, 95%CI: 0.39–2.96, P = 0.8985). Given 
the Egger intercept did not deviate significantly from zero (intercept = 0.0050, SE = 0.0157, P 
= 0.7521), there was no evidence for unbalanced pleiotropy which would suggest that the IVW 
estimates were unbiased. Also, the difference between Q and Q′ (Q - Q′ = 0.16) is not 
sufficiently extreme under a 
2
1χ  distribution, meaning, that the MR-Egger model was not a 
better fit for our data compared to the IVW model. Nonetheless, there was evidence for a 
significant heterogeneity (Q = 70.98, df = 46, P = 0.0105; and Q’ = 70.82, df = 45, P = 0.0083). 
Hence, we performed MR-PRESSO test to detect pleiotropy (global test P value = 0.011) and 
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exclude outlier variants. Our findings remain consistent with the IVW’s results even after 
correcting outlier SNPs (Table 4). The ‘distortion test` P value was 0.60 which indicates that 
there was no difference between causal estimates before and after outlier removal. Also, we 
conducted a ‘leave-one-out’ MR analysis and the results remain consistent, showing that the 
finding in the model was not driven by individual influential SNPs.  
Importantly, we replicated the results for the significant causal effect of depression on 
endometriosis using independent endometriosis and depression GWAS through the online 
platform (MR-Base). The GWAS data ‘seen doctor (GP) for nerves anxiety tension or 
depression’ (id: UKB-a:246) were utilized as the exposure variable and the ‘self-reported: 
endometriosis’ (id: UKB-b:10903) as the outcome variable. The results on the IVW (Beta = 
0.0209, SE, = 0.0060, P =0.000622), the IVW Radial (Beta = 0.0208, SE = 0.0058, P = 
0.000394), and the weighted median (Beta = 0.0191, SE = 0.00875, P = 0.0291) models, were 
consistent with our previous findings. Notably, the test for heterogeneity was not significant 
(MR Egger Q’ = 16.58, df = 17, P = 0.483; and the IVW Q = 16.79, df = 18, P = 0.537). Also, 
the MR-Egger intercept was -0.0001161 (SE = 0.000252, P = 0.651), which rules out 
significant directional pleiotropy and lends further support for a causal influence of depression 
on endometriosis.  
 
Table 4 MR results for endometriosis and depression association 
MR results of endometriosis (exposure) and depression (outcome) 
S/N Methods No of 
SNPs 
OR 95%CI P value 
1 IVW 11 1.003 0.967–1.041 8.66 × 10-1 
2 MR Egger 11 1.134 0.925–1.390 2.58 × 10-1 
3 Weighted median 11 1.018 0.979–1.059 3.71 × 10-1 
MR-PRESSO 
Method Causal estimates (Beta) OR Sd T-stat P value 
Raw 0.0032 1.003 0.019 0.168 8.70 × 10-1 
aOutlier 
corrected 
- - - - - 
Global test P value = 0.0758 
MR results of depression (exposure) and endometriosis (outcome) 
1 IVW 47 1.26 1.046–1.510 1.49 × 10-2 
2 MR Egger 47 1.07 0.390–2.960 8.99 × 10-1 
3 Weighted median 47 1.24 1.012–1.550  4.47 × 10-2 
MR-PRESSO 
Method Causal estimates (Beta)  OR Sd T-stat P value 
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Raw 0.229 1.257 0.094 2.436 1.88 × 10-2 
Outlier 
corrected 
0.193 1.213 0.087 2.211 3.21 × 10-2 
Global test P value = 0.0112 
No: Number, CI: Confidence interval, OR: Odds ratio, MR: Mendelian Randomization, IVW: inverse-variance 
weighted model, MR-PRESSO: Mendelian randomization pleiotropy residual sum and outlier, a: no outlier SNPs, 
hence no results for outlier corrected analysis.  
 
Gene-based association analyses results 
MAGMA gene-based association analysis of the endometriosis and depression GWA data 
produced results for 18,188 genes. Using a gene-based genome-wide significant threshold of 
P < 2.75 × 10-6 (Bonferroni adjustment for testing 18,188 genes [0.05/18,188]), we identified 
eight genes associated with endometriosis and 116 for depression (Supplementary Table S13). 
We assessed genes overlapping the two traits at Pgene < 0.1, resulting in a total of 768 genes 
(Supplementary Table S14). Using FCP (see method), we estimated the combined P values for 
the overlapping endometriosis and depression genes (Supplementary Table S14). FCP results 
reveal a total of 22 genes overlapping endometriosis and depression that reached a gene-based 
genome-wide significant threshold of P < 2.75 × 10-6 (Table 5A). To replicate these 22 genes, 
we utilized additional depression GWAS in performing FCP analysis. To be considered 
replicated, a gene must at least be nominally significant for endometriosis (Pgene (endometriosis) < 
0.05) and depression (Pgene (depression) < 0.05), and the FCP must be less than the respective gene 
association P values for the two traits (i.e., [Pgene (endometriosis) < 0.05] > FCP < [Pgene (depression) < 
0.05]).  
 
Using the PGC MDD GWAS we reproduced 17 of the 22 genes (Supplementary Table S15) 
three of which reached genome-wide significance (RP11-3B7.1, RHOA and CCDC71) for the 
PGC MDD (Table 5B). Also, we identified three additional genome-wide significant genes 
(C3orf84, BSN, LAMB2) in the replication analysis using the PGC MDD (Table 5B). Using the 
self-reported UKB depression GWAS, we replicated seven of the 22 genes (CABP1, FOXP1, 
UBA7, TRAIP, RNF123, RP11-3B7.1, and RHOA [borderline significance for the self-reported 
UKB depression GWAS]), as summarized in Supplementary Table S16, none of which reached 
genome-wide significance. However, two additional genes (NRG1, and KLHL18) reached 
genome-wide significance (Table 5C). 
 
Table 5 Genome-wide significant genes for endometriosis and depression  











A. IEC endometriosis and PGC-UKB Depression 
RFWD2 1 175913967 176176629 3.73 × 10-3 6.92 × 10-6 4.77 × 10-7 
CCDC71 3 49199968 49203754 3.57 × 10-4 2.50 × 10-5 1.74 × 10-7 
CCDC36 3 49235861 49295537 4.14 × 10-4 1.56 × 10-5 1.28 × 10-7 
RP11-3B7.1 3 49297518 49298744 1.22 × 10-4 6.02 × 10-6 1.62 × 10-8 
RHOA 3 49396578 49450431 1.68 × 10-4 1.84 × 10-5 6.36 × 10-8 
NICN1 3 49460379 49466759 8.49 × 10-4 4.33 × 10-6 7.51 × 10-8 
DAG1 3 49506146 49573048 9.20 × 10-4 1.13 × 10-4 1.78 × 10-6 
MST1 3 49721380 49726934 5.10 × 10-4 2.04 × 10-4 1.78 × 10-6 
RNF123 3 49726932 49758962 2.62 × 10-3 2.65 × 10-5 1.21 × 10-6 
AMIGO3 3 49754267 49761349 1.47 × 10-2 7.69 × 10-6 1.92 × 10-6 
GMPPB 3 49754277 49761384 1.47 × 10-2 7.69 × 10-6 1.92 × 10-6 
UBA7 3 49842640 49851379 4.06 × 10-3 1.02 × 10-5 7.45 × 10-7 
TRAIP 3 49866034 49894007 2.46 × 10-3 1.94 × 10-5 8.52 × 10-7 
FOXP1 3 71003844 71633140 2.13 × 10-4 1.54 × 10-4 5.99 × 10-7 
FNIP2 4 159690290 159829201 4.17 × 10-2 3.26 × 10-6 2.28 × 10-6 
GABRA1 5 161274197 161326975 6.58 × 10-3 2.45 × 10-5 2.68 × 10-6 
ESR1 6 151977826 152450754 3.15 × 10-5 3.66 × 10-3 1.96 × 10-6 
ARL14EP 11 30344598 30359774 6.80 × 10-6 3.38 × 10-3 4.27 × 10-7 
UBE4A 11 118230300 118269926 1.31 × 10-2 3.77 × 10-6 8.83 × 10-7 
ATP5L 11 118271869 118302211 2.67 × 10-2 3.98 × 10-6 1.81 × 10-6 
CABP1 12 121078355 121105127 1.46 × 10-2 2.75 × 10-6 7.22 × 10-7 
WIPI1 17 66417089 66453654 1.13 × 10-3 4.51 × 10-5 9.03 × 10-7 
B. IEC endometriosis and PGC-MDD 
C3orf84 3 49215065 49229291 8.41 × 10-5 1.02 × 10-4 1.68 × 10-7 
BSN 3 49591922 49708978 1.69 × 10-4 1.63 × 10-4 5.07 × 10-7 
RP11-3B7.1 3 49297518 49298744 1.22 × 10-4 2.89 × 10-4 6.41 × 10-7 
RHOA 3 49396578 49450431 1.68 × 10-4 3.80 × 10-4 1.12 × 10-6 
LAMB2 3 49158547 49170551 3.16 × 10-4 3.12 × 10-4 1.69 × 10-6 
CCDC71 3 49199968 49203754 3.57 × 10-4 3.82 × 10-4 2.29 × 10-6 
C. IEC endometriosis and UKB self-reported depression 
NRG1 8 31496902 32622548 1.55 × 10-4 4.11 × 10-4 1.12 × 10-6 
KLHL18 3 47324407 47388306 2.71 × 10-2 3.41 × 10-6 1.59 × 10-6 
Chr: Chromosome, IEC: International Endogene Consortium, PGC: Psychiatric Genomic Consortium, UKB: 
United Kingdom Biobank, MDD: Major Depressive Disorder, FCP: Fishers Combined P value 
 
Lastly, our independent gene-based analysis and binomial test confirmed that a significant 
gene-level genetic overlap exists between endometriosis and depression (Table 6). For 
example, the observed proportion (18.3%) of genes overlapping the two traits at Pgene < 0.05 
was significantly higher (Pbinomial-test = 2.90 × 10-4) than the expected proportion (15.0%) (Table 
6). A similar pattern of results was obtained for overlapping genes at Pgene < 0.01 (Pbinomial-test 
= 1.32 × 10-4) and Pgene < 0.1 (Pbinomial-test = 1.31 × 10-5), providing further support for a highly 
significant molecular genetic overlap between the two disorders (Table 6). 
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Table 6 Summary of independent gene-based association analysis and gene-level genetic overlap between endometriosis and depression  
 
The effective number of independent genes in endometriosis and depression 
 
Disorder Total genes P value < 0.1 P value < 0.05 P value < 0.01 
Rawc Effectived Rawc Effectived Proportione Rawc Effectived Proportione Rawc Effectived Proportione 
Endometriosisa 20,225 17,331 2,954 2,494 0.144 1,729 1,450 0.084 473 393 0.023 
Depressionb 20,225 17,223 4,769 3,909 0.227 3,194 2,576 0.150 1,428 1,109 0.064 
 
Number of overlapping genes and binomial test results for gene-level genetic overlap 
Discovery Targets Overlapping genes Proportion of overlap Binomial test p value 
Raw Effective Expected Observed 
P value < 0.01 
Endometriosis Depression 62 45 1,109/17,223 = 0.064 45/393 = 0.115 1.32 × 10-4 
P value < 0.05 
Endometriosis Depression 322 266 2,576/17,223 = 0.150 266/1450 = 0.183 2.90 × 10-4 
P value < 0.1 
Endometriosis Depression 771 656 3,909/17,223 = 0.227  656/2494 = 0.263 1.31 × 10-5 
a Endometriosis data from International Endogene Consortium, b Depression data from Psychiatric Genomics Consortium and United Kingdom Biobank (PGC-UKB), c Raw 
number of genes (total number of genes obtained in the gene-based association analysis using VEGAS2 software), d Effective number of independent genes (the total number 





Gene-drug targets results  
Our gene-drug interaction testing indicates that several of our input genes interact uniquely 
with a range of different drugs (Supplementary Table S17). The types of interactions were 
known for eight of the genes—ERBB4, CD3D, BLK, RARG, AURKB, POLE, FGFR1, HCK 
(Supplementary Table S17). Notably, CD3D interacts with BLINATUMOMAB as an 
‘activator’, while RARG interacts with ‘TRETINOIN’ as an agonist (Supplementary Table S17 
and S18). Further, our search for potential druggable targets identified 11 genes with different 
druggable characteristics (Supplementary Table S19). These include tumor suppressor (RHOA, 
CCDC36), DNA repair (UBA7), serine-threonine kinase (RHOA, MST1), transporter and ABC 
transporter (ATP5L, GABRA1) and ion channel (GABRA1), among others (Supplementary 
Table S19). 
 
Results of pathway-based functional enrichment analysis 
Table 7 presents our findings for pathway-based functional enrichment analysis for genes 
overlapping both endometriosis and depression at Pgene < 0.1 (Pbinomial-test = 1.31 × 10-5). A total 
of seven genetically influenced biological pathways were significantly enriched including, 
‘calcium-dependent cell-cell adhesion’ (P(adjusted) = 1.25 × 10-2), and ‘inositol phosphate 
metabolism’ (P(adjusted) = 5.65 × 10-3). Others include ‘Hippo-Merlin Signaling Dysregulation’ 
(P(adjusted) = 2.75 × 10-2), ‘peptic ulcer’ (P(adjusted) = 1.61 × 10-3), and ‘hypoplastic toenails’ 
(P(adjusted) = 3.65 × 10-2). Further details about these pathways including genes implicated are 
presented in Table 7. Notably, ‘pathways regulating Hippo Signaling’ (P(adjusted) = 2.52 × 10-5), 
and ‘abnormality of the gastric mucosa’ (P(adjusted) = 1.23 × 10-4) produced the most statistically 
significant enrichment. Given that several related or overlapping pathways may be significantly 
enriched, we organized the overrepresented pathways found in the present study into clusters 
based on their biological themes. This practice eliminates redundancy and enhances both the 
visualization as well as the interpretation of significantly enriched pathways. We utilized the 
‘auto-annotate’ software for this analysis, thereby identifying three clusters of pathways 








Table 7 Significantly enriched pathways for endometriosis and depression  





Gene Ontology: Biological Process 
Calcium-dependent 
cell-cell adhesion via 
plasma membrane cell 
adhesion molecules 
GO: 0016339 1.25 × 10-2 CDH13, CDH9, CDH22, PCDHB5, PCDHB4, 







5.65 × 10-3 IP6K1, PLCB3, INPP5A, IMPA1, PLCH1, 
INPP5B, ISYNA1, PLCH2, MTMR9, INPPL1 
Biological Pathways: WikiPathways 
Pathways Regulating 
Hippo Signaling 
WP: WP4540 2.52 × 10-5 CDH13, RHOA, MST1, CDH9, CDH22, 
PRKCD, PLCB3, NTRK2, PRKAR2A, LATS1, 





WP: WP4541 2.75 × 10-2 CDH13, MST1, LIN28B, CDH9, CDH22, 
NTRK2, PRKAR2A, ITGB8, LATS1, FGFR1, 
CDH8, LATS2, AJUBA, CDH12 
Biological Pathways: Human Phenotype Ontology 
Abnormality of the 
gastric mucosa 
HP: 0004295 1.23 × 10-4 ABCC2, PRKCD, GTF2I, ARID1B, CISD2, 
CLIP2, ERGIC1, RASGRP1, LIMK1, WFS1 
Peptic ulcer HP: 0004398 1.61 × 10-3 GTF2I, ARID1B, CISD2, CLIP2, ERGIC1, 
LIMK1, WFS1, CDKN2C 
Hypoplastic toenails HP: 0001800 3.65 × 10-2 SMARCE1, GTF2I, ARID1B, CLIP2, FGFR1, 




Fig. 1 Significantly enriched pathways for endometriosis and depression 
Clustered biological themes of significantly enriched biological pathways for overlapping endometriosis-
depression genes 
 
‘Abnormality of gastric mucosa’ implicated in the biological mechanisms of both 
endometriosis and depression, and, likely in their comorbidity, in the present study, came 
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across as a noteworthy finding. Hence, using GWAS summary data, readily available in the 
public domain, we carried out a follow-up analysis to examine the relationship between each 
of endometriosis and depression and two of gastric mucosa-related disorders—
gastroesophageal reflux disease (GERD) and gastritis/duodenitis, respectively (see 
Supplemental Note 2 for a comprehensive description of this assessment). 
Our findings are summarized in Fig. 2. Briefly, LDSC regression analysis reveals a positive 
and highly significant genetic correlation between endometriosis and GERD (rG = 0.24, P = 
1.17 × 10-20) [Fig. 2]. There was also evidence for a positive and significant genetic correlation 
between endometriosis and gastritis/duodenitis (rG = 0.18, P = 1.5 × 10-3) [Fig. 2]. Furthermore, 
we found a strong, positive and highly significant genetic correlation between depression and 
GERD (rG = 0.52, P = 1.96 × 10-145), as well as between depression and gastritis/duodenitis (rG 
= 0.51, P = 3.21 × 10-14) [Fig. 2].  
A further assessment using the IVW model in a “TwoSampleMR” analysis indicates no 
evidence for a causal association when endometriosis was assessed as an exposure variable 
against GERD as an outcome (Supplemental Note 2). Conversely, when we assessed GERD as 
exposure and endometriosis as an outcome variable, we found a significant causal association 
between the two traits (IVW OR = 1.30, P = 0.00653) [Fig. 2, and Supplementary Table S20]. 
There was no evidence for significant heterogeneity (MR Egger Q’ = 30.75, df = 22, P = 0.102; 
and the IVW Q = 30.85, df = 23, P = 0.125). Also, the test for directional pleiotropy was not 
significant (Egger intercept = 0.0078, SE = 0.0270, P = 0.773). Sensitivity analyses using the 
‘weighted median’ model (close to border-line significance) and MR Egger models did not 
support findings for IVW model in this instance (Supplemental Note 2 and Supplementary 
Table S20). However, as indicated by the difference between Q and Q’, the MR-Egger model 
was not a better fit for our data compared to the IVW (Supplementary Table S20). Importantly, 
the MR-PRESSO results were consistent with those of the IVW model (global test P value = 
0.137 [supporting evidence of no horizontal pleiotropy]; outlier test = no outlier variants; and 
raw causal OR = 1.301, P = 0.0122). The leave-one-out analysis was similarly consistent 
indicating that the association was not driven by individual influential SNPs.  
In a related assessment, we found a highly significant bidirectional causal association between 
depression and GERD (depression as an exposure variable versus GERD as an outcome 
variable: OR = 1.56, P = 2.39 × 10-23; GERD as an exposure variable versus depression as an 
outcome variable: OR =1.30, P = 3.66 × 10-9) [Fig. 2 and Supplementary Table S21]. Also, MR 
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provides evidence for a causal association between depression and gastritis/duodenitis 
(depression as an exposure variable versus gastritis/duodenitis as an outcome variable OR = 
1.29, P = 0.000567) [Fig. 2 and Supplementary Table S22]. Sensitivity tests using the ‘weighted 
median’ model support all results for the IVW model. Although the MR Egger model supports 
IVW only in respect of depression (exposure variable) vs GERD (outcome variable), the MR-
PRESSO was consistent with the IVW model in all analyses (see Supplemental Note 2 and 
Supplementary Table S22 for details). 
Last, we did not find a significant causal association between endometriosis (as exposure 
variable) and gastritis/duodenitis (as outcome variable) [IVW OR = 1.039, P = 0.35] 
[Supplemental Note 2 and Supplementary Table S20]. No genome-wide significant SNP was 
associated in gastritis/duodenitis GWAS summary data (violation of the first MR assumption), 
hence further analysis—gastritis/duodenitis vs endometriosis and gastritis/duodenitis vs 
depression—were not conducted. Taken together, our study implicates abnormal conditions of 
gastric mucosa in the causal pathways of endometriosis and depression as summarized in Fig. 
2.  
 
Fig. 2 Associations between endometriosis, depression, GERD and gastritis/duodenitis 
Path diagram summarizing the relationship (correlation and causal association) between endometriosis, 
depression and two abnormal conditions of gastric mucosa (GERD and gastritis/duodenitis) found in our study. 
GERD: gastroesophageal reflux disease. The dashed bidirectional arrowhead line describes correlation 
relationships based on linkage disequilibrium score regression analyses (LDSC) results. rG: genetic correlation 
obtained for the pairs of traits in the LDSC. P: P value. a: causal relationship between GERD (as the exposure) 
and depression (as the outcome), odds ratio (OR) = 1.30, P = 3.66 × 10-9. b: causal relationship between depression 
(as exposure) and GERD (as outcome), OR = 1.56, P = 2.39 × 10-23. c: causal relationship between depression (as 
exposure) and endometriosis (as outcome), OR = 1.26, P = 1.49 × 10-2. d: causal relationship between GERD 
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(exposure) and endometriosis (outcome), OR = 1.30, P = 6.53 × 10-3. e: causal relationship between depression 
(exposure) and gastritis/duodenitis (outcome), OR = 1.29, P = 5.67 × 10-4. 
 
Discussion 
We assessed the comorbidity of endometriosis and depression using several statistical methods 
and performing both SNP- and gene-level analyses. Well-powered GWAS summary data from 
large research consortia were utilized for analysis. To our knowledge, this is the first study to 
comprehensively assess the relationship between endometriosis and depression by analyzing 
GWAS data. Findings from SECA and LDSC regression analyses indicate that a highly 
significant SNP-level genetic overlap and correlation exist between endometriosis and 
depression. For example, of the 1,844 independent SNPs associated with both endometriosis 
and depression at P < 0.05 (SNP subset having P1 and P2 < 0.05, see methods), a total of 1,065 
(57.8%) showed evidence of significant concordance effects (OR = 1.86, PFisher’s-exact = 4.72 × 
10-11) in SECA. Consolidating the findings for SECA, bivariate LDSC regression analysis 
estimates a positive and highly significant genetic correlation between the two traits.  
Traditional observational studies have reported conflicting findings for the co-occurrence of 
endometriosis and depression (Cavaggioni et al. 2014; Chen et al. 2016; Gambadauro et al. 
2019; Novais et al. 2018). However, the significant genetic overlap and correlation between 
the two disorders found in our study confirm their comorbidity and indicate that, at the least, a 
proportion of endometriosis and depression patients share similar genetic etiology. Supporting 
this position, the independent gene-based test reveals the presence of a highly significant gene-
level genetic overlap between endometriosis and depression. Our study was based on the 
analysis of genotype data; hence, findings are reliable and are not likely to suffer from 
methodological complications such as the bias of reverse causation or the confounding effects 
of lifestyles and/or environments, unlike the traditional observational studies.  
Leveraging on the power afforded by data pooling and our finding of highly significant genetic 
overlap between endometriosis and depression, we meta-analyzed the respective GWAS 
summary statistics to discover susceptibility loci shared by both traits. Notably, our cross-
disorder GWAS meta-analysis identified 20 independent genomic loci reaching genome-wide 
significance. Eight of the loci have not previously been reported for either endometriosis or 
depression at a genome-wide significant level, indicating them to be novel risk loci. The 
remaining twelve loci were either at or near a previously identified depression locus, and our 
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study reveals their potential involvement in both disorders, and perhaps their comorbid state. 
The identified novel SNPs and loci mapped to several genes including TNR, BRINP3, 
CC2D2A, TACR3, C6orf118, GSDMC, PCDH17, and NR2F2. The TNR gene is predominantly 
expressed in the brain and is involved in the focal adhesion pathway and microglia activation 
in neuroinflammation (Anlar and Gunel-Ozcan 2012; Roll and Faissner 2019) which may 
support the roles of the pathways (focal adhesion and neuroinflammation) in the pathogenesis 
of endometriosis and depression. Indeed, the genomic region harboring this gene has been 
implicated in some brain disorders like Alzheimer’s disease, schizophrenia, neurological sleep 
disorder and narcolepsy (Zuo et al. 2012). NR2F2 is similarly expressed in the brain, but more 
broadly in the ovary, endometrium, spleen as well as in several other tissues including the heart, 
kidney and gastrointestinal organs like the stomach, colon, duodenum, and esophagus (Lin et 
al. 2011). Pathogenic mutation in this gene has been implicated in cardiovascular disorders 
including congenital heart defects (Al Turki et al. 2014; Wang et al. 2019).  
We replicated many of the loci (identified in our meta-analysis) using separate depression 
GWAS data, with some reaching genome-wide suggestive association—supporting evidence 
of their involvement in both traits. We note that the ‘PGC_UKB depression’ (n = 500,199) 
GWAS data, utilized in the initial meta-analysis, were better powered. Hence, it is not 
surprising that the replication analyses, using the less powerful ‘PGC 2018 MDD 
excl23andMe’ (n = 173,005) and ‘self-reported depression UKB’ (n = 289,307) GWAS, did 
not replicate loci reaching a genome-wide significance unlike in the primary cross-disease 
meta-analysis (for IEC endometriosis and the PGC_UKB depression GWAS). One of the more 
noteworthy findings in our replication analyses is the potential for identifying robust SNPs and 
loci, for endometriosis and depression, by meta-analyzing their respective GWAS data. For 
example, the SNPs (rs116810322, rs6808036, rs1931388 and rs323509) we identified, were 
genome-wide significant for depression in previous GWAS studies (Howard et al. 2019; Nagel 
et al. 2018) but not in the ‘PGC 2018 MDD’ used for replication testing in the present study. 
Following the meta-analysis of the ‘IEC endometriosis’ and the ‘PGC 2018 MDD’ GWAS, the 
named SNPs attained genome-wide significance, supporting our premise, and confirming 
evidence of shared genetics between endometriosis and depression. 
We conducted MR analyses and our findings provided evidence of a causal association between 
depression (as the exposure variable) and endometriosis (as the outcome variable). We 
compared the results of the IVW model with three other MR methods (the weighted median, 
the MR-Egger and the MR-PRESSO) since consistent estimates across the four models may 
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strengthen evidence of a causal association. The MR-Egger method did not support the causal 
effects of depression on endometriosis which may indicate sampling variations or a possible 
violation of MR assumptions (Bowden and Holmes 2019). However, the weighted median 
model was consistent with that of the IVW. In instances where most IVs are valid, the weighted 
median method is known to be more precise than the MR-Egger model (Burgess and Thompson 
2017), which may be the case in our study given the wide confidence interval of the MR-
Egger’s result. Other assessments carried out indicate that MR assumptions were not violated. 
For example, the Egger intercept was not significantly different from zero indicating that there 
was no unbalanced pleiotropy. While there was evidence for heterogeneity, the MR-PRESSO 
test excluded outlier SNPs and the results before and after outlier correction were consistent 
with those of the IVW model. Notably, using independent GWAS data for the respective traits, 
we replicated the causal effect of depression on endometriosis, in the online platform of MR 
analysis (the MR-Base), with no evidence for directional pleiotropy or heterogeneity. 
The biological mechanism underpinning the causal influence of depression on endometriosis 
is, however, unclear; and to our knowledge, this is the first study to suggest this causal 
relationship. The finding is, nonetheless, consistent with a recent longitudinal study which 
found bidirectional associations between endometriosis and depressive disorders (Gao et al. 
2020). A potential explanation for the relationship would be the likely roles of the immune 
system and inflammatory pathways which have been implicated in depression. For example, 
immune system dysregulation, in the central nervous system, may activate inflammatory 
responses, and in a prolonged state, inhibits apoptosis, as well as alters DNA repairs (Chida et 
al. 2008; Fedeles et al. 2015). These processes have been suggested in the relationship between 
depression and cancer (Chida et al. 2008; Fedeles et al. 2015) and may be relevant in the present 
findings given that inflammatory and immune system dysfunction have similarly been 
implicated in endometriosis (Adewuyi et al. 2020; Ahn et al. 2015; Miller et al. 2017). 
Moreover, higher levels of inflammatory and pro-inflammatory biomarkers including C-
reactive protein, tumor necrosis factor and interleukins have been associated with both 
depression and endometriosis (Adewuyi et al. 2020; Kim et al. 2016), providing further support 
for our findings.  
Reversing the direction of our analysis, MR found no evidence for a causal relationship 
between endometriosis (as an exposure variable) and depression (as an outcome variable). This 
non-significant finding may be because of the fewer number of endometriosis SNPs available 
as IVs which may have resulted in limited power to detect a causal association in MR. Hence, 
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we cannot completely rule out the possibility of a causal effect of endometriosis on depression. 
A re-assessment of this finding, when more genome-wide significant SNPs for endometriosis 
are available, should clarify these results. 
To complement our SNP-level analyses, we further assessed the relationship between 
endometriosis and depression using gene-based association analyses. Gene-based analyses 
have the potential to be more powerful over SNP-based analyses and may provide mechanistic 
insights into the biology of complex diseases. Our analysis identified 22 genes with a combined 
gene-based genome-wide significant P value for endometriosis and depression. A gene-drug 
targets search revealed that some of these significant genes are known for crucial biological 
roles including tumor suppression (RHOA, CCDC36), DNA repair (UBA7), transcription factor 
binding (ESR1), transport activities (ATP5L, GABRA1) and ion channel functions (GABRA1). 
Also, one of the genes, ARL14EP at the 11p14.1 locus, previously implicated in endometriosis, 
and several female hormone-related traits (Adewuyi et al. 2020; Mbarek et al. 2016; Ruth et 
al. 2016a; Ruth et al. 2016b; Sapkota et al. 2017), was associated with both endometriosis and 
depression in the present study. 
Drawing on the strength of a systematic literature review and meta-analysis of cross-sectional 
studies, a recent study has suggested that chronic pain largely explains endometriosis and 
depression association (Gambadauro et al. 2019). Evidence that pain is often associated with 
both endometriosis and depression (Bair et al. 2003; Demyttenaere et al. 2007; Facchin et al. 
2015; Holmes et al. 2013; Sheng et al. 2017) may support its potential role in the two disorders, 
and possibly in their co-occurrence. Also, our study, implicating genes involved in 
inflammatory or neuroinflammatory processes (e.g., TNR and NF2) (Anlar and Gunel-Ozcan 
2012; Omoigui 2007; Roll and Faissner 2019), in both endometriosis and depression, 
potentially suggests a role for pain, since inflammation and inflammatory response underlie 
the origin of pain (Omoigui 2007). Moreover, inflammatory mediators including interferon-
gamma (IFN-γ), interleukin, and tumor necrosis factor-alpha (TNF-α) are parts of the 
mechanisms represented by the hippo signalling pathways (Zhou et al. 2018) identified in our 
study.  
We note, however, that our study does not support pain (or chronic pain) as the determinant of 
the association between endometriosis and depression, in the classic or suggested way of pain 
in endometriosis leading to depression (i.e., depressed due to being in pain). While 
Gambadauro and colleagues’ meta-analysis suggested that ‘chronic pain, rather than 
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endometriosis itself, is the main determinant of depressive symptoms’ (Gambadauro et al. 
2019, pp238), the present study indicates that both endometriosis and depression share similar 
genetic etiology. First, genetic overlap assessment supports evidence of shared genetic 
susceptibility for both disorders. Indeed, we identify SNPs, genes and loci shared by both 
disorders. Second, our MR analysis suggests a causal relationship between endometriosis and 
depression and the direction of causation indicates endometriosis as the outcome. Last, the use 
of genotype data (as done in the present study) means the inheritance of shared genetic variants 
for the two traits preceded lifestyle and environmental exposures which would negate the 
suggestion that endometriosis-induced pain explains comorbid depression.  
For further insight into the underlying biology of endometriosis and depression, we performed 
pathway-based functional enrichment analysis and identified seven genetically influenced 
biological pathways and processes shared by the two traits. For ease of visualization or 
interpretation, the identified pathways were grouped into three broad themes and clusters: ‘cell 
adhesion hippo signaling’, ‘inositol phosphate metabolism’ and ‘abnormality of gastric 
mucosa’ significantly enriched for endometriosis and depression. The first cluster, cell 
adhesion hippo signaling, comprises three pathways: ‘hippo-merlin signaling dysregulation’, 
‘pathways regulating hippo signaling’ and ‘calcium-dependent cell-cell adhesion’. Merlin is a 
multifunctional protein that integrates as well as regulates both extra- and intracellular 
signaling pathways maintaining cell size, motility, shape and survival (Stamenkovic and Yu 
2010). The protein is encoded by the NF2 gene and known to be a tumor suppressor 
(Stamenkovic and Yu 2010). 
Hippo signaling pathway, also known to be a tumor suppressor, ensures a balance between 
apoptosis and cell proliferation, and it is activated and regulated by merlin (Li et al. 2015; 
Stamenkovic and Yu 2010). Dysregulation of this pathway is believed to contribute to 
decreased apoptosis and increased cell proliferation. Evidence similarly indicates that merlin 
regulates cell-cell and cell-matrix adhesion (Stamenkovic and Yu 2010). Furthermore, inositol 
phosphate metabolism pathway is critical to several physiological activities including 
apoptosis, endocytosis, cell migration or proliferation, vesicle trafficking, PI3K/Akt and insulin 
signalling (Tan et al. 2015). The dysregulation of this pathway has been noted in cancers (Tan 
et al. 2015). The recognition that endometriosis sometimes behaves as a tumor (Guo 2018) 
may, thus, be consistent with the dysregulation of the hippo-merlin as well as the inositol 
phosphate metabolism pathways. In support of our findings, hippo signaling pathways have 
been implicated in endometriosis (Song et al. 2016). In the case of depression, we do not have 
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previous evidence implicating the ‘hippo-merlin-cell-adhesion’ signaling pathways; however, 
mechanisms represented by those, for example, apoptosis, inflammation and cell proliferation 
have been reported in depression (McKernan et al. 2009; Shelton et al. 2011; Zhou et al. 2018). 
‘Gastric mucosa abnormality’ emerged as one of the most significantly enriched findings in 
our pathway-based analysis. A follow-up study indicates the presence of a strong and highly 
significant genetic correlation between each of endometriosis and depression, and the 
respective ‘gastric mucosa abnormality’ traits, GERD and gastritis/duodenitis, assessed in the 
follow-up analysis. These findings are not only consistent with previous observational evidence 
(Choi et al. 2018; Haug et al. 2002; Kvaskoff et al. 2015; Parazzini et al. 2017; Roman et al. 
2012), they confirm a comorbid relationship between the respective pairs of the disorders—
endometriosis and GERD, endometriosis and gastritis/duodenitis, depression and GERD, and 
depression and gastritis/duodenitis. This would mean that both endometriosis and depression 
share some genetic predisposition with GERD, gastritis/duodenitis and by extension, peptic 
ulcer disease, implicating shared genetically determined mechanisms underlying their 
association.  
The exact biological mechanism(s) underlying the roles of gastric mucosa in the pathobiology 
of endometriosis and depression, remains unclear. However, the effects of certain immune 
system and inflammatory mediators—interferon-gamma (IFN-γ), interleukin, and tumor 
necrosis factor-alpha [TNF-α] (Altomare et al. 2013; Kim et al. 2018)—may be a likely 
explanation. These mediators are highly concentrated in the gastric or esophageal mucosa of 
patients suffering an associated disorder, and are believed to up-regulate inflammatory 
responses in the central nervous system which may predispose to depression (Altomare et al. 
2013; Berk et al. 2013; Lampa et al. 2012). In the same vein, a comorbid relationship has been 
reported between endometriosis and gastrointestinal symptoms (Parazzini et al. 2017). Given 
that inflammation has long been associated with both endometriosis and depression (Berk et 
al. 2013), this position supports current findings. Moreover, abnormal conditions of gastric 
mucosa (GERD, gastritis, peptic ulcer disease), implicated in our study, have inflammatory 
components. Thus, ‘gastric mucosa abnormality’ may represent an important link in the causal 
pathways of endometriosis and depression and probably in the comorbid state of the two 
disorders.  
A further assessment using the MR analysis suggests causal associations of both endometriosis 
and depression with at least one of GERD and/or gastritis/duodenitis. We found a causal effect 
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of GERD on endometriosis as well as a bidirectional causal relationship between depression 
and GERD. The finding for depression and GERD agrees not only with a previous 
observational study (Kim et al. 2018) but also a recent GWAS analysis (Wu et al. 2019). Hence, 
causality may indeed explain the comorbidity of depression with GERD. On the other hand, 
while no previous study has reported a causal influence of GERD on endometriosis, 
observational evidence supports a comorbid relationship between endometriosis and several 
gastrointestinal disorders (Parazzini et al. 2017). Thus, gastric mucosa disorders may be a basis 
for the co-occurrence of endometriosis and depression. It is logical to suggest that the 
relationship between endometriosis and gastric mucosa traits could be due to the ulcerogenic 
tendencies of non-steroidal anti-inflammatory drugs commonly used in the treatment of 
endometriosis-associated pain. However, given the use of genotype data and the direction of 
causality (endometriosis as the outcome) found in our study, such a suggestion will not be 
consistent with the present study. 
Taken together, we hypothesize that, abnormal conditions of gastric mucosa (e.g., GERD, 
gastritis and peptic ulcer) are causal risk factors for endometriosis. The role(s) of these risk 
factors may be through the direct causal effect or a link with depression or by mediating the 
relationship between comorbid endometriosis and depression. Further, we propose that 
effective treatment of underlying GERD (and other gastric mucosal abnormality traits 
including peptic ulcer disease) may be of therapeutic relevance in comorbid endometriosis. 
Recent observational studies suggest improved outcomes for endometriosis and 
gastrointestinal symptoms following dietary considerations (Borghini et al. 2020; Moore et al. 
2017). At the end of a three-month administration of a low nickel diet, there was a significant 
improvement for endometriosis and gastrointestinal-like symptoms (Borghini et al. 2020). A 
similar finding has been reported for a low FODMAP (fermentable oligosaccharides, 
disaccharides, monosaccharides and polyols) diet (Moore et al. 2017). Thus, dietary approaches 
may be potentially beneficial in comorbid endometriosis and depression. Further investigation 
of the approach, for example, using randomized control trials, may be warranted in the context 
of the present study. 
Conversely, non-steroidal anti-inflammatory drugs are first-line pharmacological agents for 
endometriosis-associated pain (Giudice 2010; Schwartz et al. 2020). These medications are 
contra-indicated (or at the least should be used with caution) in GERD, gastritis, peptic ulcer 
and indeed all conditions involving a compromised state of the gastric mucosa (Drini 2017). 
Also, certain proton pump inhibitors (medications for managing GERD, gastritis, and peptic 
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ulcer) have been associated with depression risk (Huang et al. 2018; Laudisio et al. 2018). 
Hence, as a matter of diagnostic and treatment practices, there is a need for thorough symptom 
investigations to rule out comorbid gastric mucosa abnormal conditions and depression before 
initiating these medications. 
Strengths and Limitations 
The use of multiple statistical methods means a comprehensive, complementary, and balanced 
assessment of the subject matter and represents a major strength of the present study. Unlike 
the conventional observational studies, which are prone to the bias of reverse causation and 
confounding effects of environments or lifestyles, our study is generally not susceptible to these 
limitations given it was based on the analysis of genotype data. Accordingly, our findings 
provide current and robust evidence on the co-occurrence of endometriosis and depression by 
analyzing GWAS data. Nonetheless, it is important to consider some limitations in interpreting 
findings in the present study.  
First, the bias of sample overlap is likely between depression and GERD in our follow-up study 
since the depression and GERD GWAS data were both partly sourced from the UK Biobank. 
Such sample overlap is, however, unlikely to have affected our LDSC regression findings since 
we did not constrain any of the intercepts involving depression GWAS (in the follow-up 
analysis). Also, our MR analysis is not likely to have produced a biased conclusion given the 
consistency of its findings with previous observational studies and a recent GWAS-based 
analysis (Kim et al. 2018; Wu et al. 2019). Second, our study was based on the analysis of data 
from mainly European ancestry, hence, readers need to exercise caution in generalizing 
findings to other ancestries. Last, some of the significantly enriched pathways/mechanisms in 
the pathway-based functional enrichment study could be redundant, thus, we collapsed related 
pathways into simplified themes/clusters using enrichment mapping and auto-annotation 
methods thereby enhancing the interpretation and visualization of our results.  
Conclusions 
Our study provides strong evidence for the co-occurrence of endometriosis and depression, 
indicating that the two traits share similar genetic etiology. We identified 20 genome-wide 
significant independent genomic loci, eight of which are novel, and 22 genome-wide 
significant genes shared by both disorders. Also, we demonstrated a causal influence of 
depression on endometriosis and identified three clusters of biological pathways for the two 
traits (‘cell adhesion hippo signaling’, ‘abnormality of gastric mucosa’ and ‘inositol phosphate 
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metabolism’). These pathways potentially implicate biological processes such as cell 
proliferation, apoptosis, cell adhesion, as well as the possible roles of the immune system and 
inflammatory mediators including interferon-gamma (IFN-γ), interleukin, and tumor necrosis 
factor-alpha (TNF-α). Notably, gastric mucosa disorder traits were implicated in the causal 
pathways of both endometriosis and depression. Our study, thus, highlights the importance of 
screening for endometriosis among women presenting with depression and gastric mucosa 
abnormality traits including GERD, gastritis, duodenitis, and peptic ulcer disease and vice 
versa. Genes and pathways identified in our study could serve as potential druggable targets 
for endometriosis and depression and especially the comorbid state of the two disorders. We 
propose, given the novelty of our findings, that effective treatments for gastric mucosa diseases 
or depression may find relevant therapeutic benefits for improved outcomes in comorbid 
endometriosis. Also, we suggest possible benefits of dietary approaches in comorbid 
endometriosis and depression given their association with gastric mucosal abnormalities. 
Future studies using prospective follow-up or randomized control trial designs will need to 
assess these proposals.  
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